Other top stories

Stable Outcomes Seen in Transition to Xanomeline-Trospium Therapy for Schizophrenia

October 28, 2025

Real-World Transition Strategies for Initiating Xanomeline–Trospium in Schizophrenia

October 28, 2025

AI Counselors Cross Ethical Lines

October 24, 2025

Weekly Mind Reader: When Doctors Feel Too Much

October 24, 2025

Tobacco Use Could Magnify Cannabis-Linked Brain Changes

October 23, 2025

New Clues Why Schizophrenia Patients Hear Voices

October 22, 2025

Other stories

Strong Social Bonds Might Help Slow Aging

October 21, 2025

How a Simple Satisfaction Score Might Save Healthcare Workers

October 20, 2025

Hospice Sedatives May Hasten Death in Dementia Patients

October 17, 2025

Weekly Mind Reader: Autoimmune Diseases Linked to Dementia

October 17, 2025

Mental Health Progress Stalls At A Crossroads

October 16, 2025

How Social Thinking Shapes Recovery in Early Schizophrenia

October 15, 2025

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure. Image of a syringe on two vials highlights aripiprazole monohydrate LAI clinical use in Bipolar I Disorder.

Subscribe to read
more articles

Subscribe